We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

31 hedge funds and large institutions have $16.8M invested in Capricor Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more capital invested

Capital invested by funds: $8.87M → $16.8M (+$7.88M)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

20% more call options, than puts

Call options by funds: $2.28M | Put options by funds: $1.9M

7% more funds holding

Funds holding: 29 → 31 (+2)

1.01% more ownership

Funds ownership: 10.46% → 11.47% (+1%)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
9
Closed
4
Calls
$2.28M
Puts
$1.9M
Net Calls
+$385K
Net Calls Change
+$665K

Top Buyers

1
BlackRock
BlackRock
New York
+$708K
2
Simplex Trading
Simplex Trading
Illinois
+$269K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$192K
4
Millennium Management
Millennium Management
New York
+$140K
5
CSS
Cubist Systematic Strategies
Connecticut
+$117K

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$124K
2
UBS Group
UBS Group
Switzerland
-$102K
3
Citadel Advisors
Citadel Advisors
Florida
-$54.3K
4
Charles Schwab
Charles Schwab
California
-$52K
5
Group One Trading
Group One Trading
Illinois
-$40.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$7.03M +$192K +37,500 +3%
BlackRock
2
BlackRock
New York
$2.62M +$708K +138,347 +46%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.33M +$81.7K +15,970 +8%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$978K +$49.6K +9,706 +6%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$873K -$124K -24,206 -14%
Northern Trust
6
Northern Trust
Illinois
$631K +$20K +3,905 +4%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$508K – – –
State Street
8
State Street
Massachusetts
$475K – – –
Simplex Trading
9
Simplex Trading
Illinois
$414K +$269K +52,528 +316%
Group One Trading
10
Group One Trading
Illinois
$276K -$40.1K -7,846 -15%
Morgan Stanley
11
Morgan Stanley
New York
$238K +$9.31K +1,820 +5%
Citadel Advisors
12
Citadel Advisors
Florida
$217K -$54.3K -10,614 -23%
B
13
Bailard
California
$202K +$19.4K +3,800 +13%
Millennium Management
14
Millennium Management
New York
$164K +$140K +27,288 New
Goldman Sachs
15
Goldman Sachs
New York
$150K +$77 +15 +0.1%
CSS
16
Cubist Systematic Strategies
Connecticut
$138K +$117K +22,955 New
JF
17
Jump Financial
Illinois
$136K +$116K +22,600 New
HighTower Advisors
18
HighTower Advisors
Illinois
$102K -$18.4K -3,599 -18%
CBA
19
Coastal Bridge Advisors
Connecticut
$65K – – –
Renaissance Technologies
20
Renaissance Technologies
New York
$61K +$52.2K +10,200 New
US Bancorp
21
US Bancorp
Minnesota
$45K – – –
Osaic Holdings
22
Osaic Holdings
Arizona
$30K – – –
CG
23
Cutler Group
California
$22K – – –
Bank of America
24
Bank of America
North Carolina
$21K -$7.67K -1,500 -30%
FDCDDQ
25
Federation des caisses Desjardins du Quebec
Quebec, Canada
$11.6K -$17.3K -3,374 -64%
1
2

CAPR Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q3 2022, worth a combined $16.8M — up 89% from $8.87M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CAPR positions and 4 closed out — a net gain of 2 holders — while 9 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $708K. The largest seller was Susquehanna International Group, cutting an estimated $124K.

  • 31 institutional investors held Capricor Therapeutics (CAPR) as of Q3 2022, up from 29 in Q2 2022.
  • Funds reported $16.8M of Capricor Therapeutics stock for Q3 2022, up 89% quarter-over-quarter.
  • 6 funds opened new Capricor Therapeutics positions in Q3 2022 and 4 closed out, a net change of +2 holders.
  • The largest Capricor Therapeutics buyer in Q3 2022 was BlackRock, an estimated $708K added.
  • The largest Capricor Therapeutics seller in Q3 2022 was Susquehanna International Group, an estimated $124K sold.

Based on aggregated 13F filings for Q3 2022.